Why the study?
Does the lazaroid U-74389G mitigate postresuscitation myocardial dysfunction and improve survival in a rodent model of ventricular fibrillation?
Does the lazaroid U-74389G mitigate postresuscitation myocardial dysfunction and improve survival in a rodent model of ventricular fibrillation?
In a rodent model of cardiac arrest, administration of the lazaroid U-74389G mitigated postresuscitation myocardial dysfunction and improved survival.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for lazaroid use after cardiac arrest; prospective human trials needed before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: